SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-007460
Filing Date
2019-10-07
Accepted
2019-10-07 07:05:25
Documents
2
Period of Report
2019-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_100719.htm 8-K 18697
2 PRESS RELEASE DATED OCTOBER 7, 2019 ex99-01.htm EX-99.01 12398
  Complete submission text file 0001387131-19-007460.txt   32287
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 191139630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences